Among other deterrents, the biological clock is one of the&nbsp;factors that pose a roadblock in women's career progression. Women face sexism, unequal pay, gender stereotypes, fewer promotions, and other inequalities in workplaces; and learn to fight them all. But in order to maintain respectable career growth, women often sideline their health which keeps deteriorating with time.&nbsp;

One such health-related concern is the stage of menopause, which is a natural decline in reproductive hormones when a woman reaches her 40s or 50s. Menopause means that your menstrual cycles are ending. This natural biological process is diagnosed after you've gone 12 months without a menstrual period.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/health-and-wellness/rising-cases-of-silent-heart-attacks-linked-to-long-covid-wion-decodes-687662">Rising cases of silent heart attacks linked to long Covid? WION decodes</a>&nbsp;

Despite being a natural process, the physical and mental symptoms of menopause, such as hot flashes, can disrupt your sleep, diminish your energy, and have an impact on your emotional health.&nbsp;

WION got in touch with experts to know how women can embrace this crucial phase along with focusing on their career and personal life.&nbsp;

Dr Rituparna Ghosh, Consultant Senior Clinical Psychologist, Apollo Hospitals, Navi Mumbai told WION, "Embracing menopause with confidence means acknowledging its challenges while harnessing the resilience and wisdom gained from navigating life's transitions."

"Let us foster environments where women feel empowered to seek support, openly discuss their experiences, and embrace self-care practices that nurture their mind, body, and spirit. Together, let's dismantle stigmas surrounding menopause and empower women to embrace this chapter of life with confidence, resilience, and a renewed sense of purpose," she added. &nbsp;&nbsp; &nbsp;

Dr VK Shantha, MD, DGO, DNB, Senior Consultant Obstetrician &amp; Gynecologist, BirthRight by Rainbow Hospitals, Anna Nagar, Chennai told WION, "The menopausal transition is a crucial phase in a woman's life, with various changes such as caring for ageing parents, supporting children, and accepting new obligations."&nbsp;

The World Health Organization (WHO) states that most women go through menopause between the ages of 45 and 55 as a natural component of biological ageing. Some women are luckier than the&nbsp;rest and face fewer issues with menstrual symptoms, while others go through hot flashes, difficulty in sleeping, sexual dysfunction, mood swings, anger, sadness, or a combination of these symptoms, encouraging them to seek treatment.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/science/research-outlines-significant-changes-that-happen-to-body-during-pregnancy-687587">Research outlines significant changes that happen to body during pregnancy</a>&nbsp;

A decades-old study had accurately projected the future as it noted that using age 50 as a proxy for menopause, about 25 million women pass through menopause each year. The study estimated that in 1990 there were 467 million post-menopausal women in the world, with an average age of about 60 years.&nbsp;It mentioned that by 2030, the world population of menopausal and postmenopausal women is projected to increase to 1.2 billion, with 47 million new entrants each year.&nbsp;

Dr Shantha added, "As medical professionals, we must acknowledge this natural shift and provide women with the knowledge, support, and confidence they require to manage it with grace and resilience."&nbsp;

"Women need comprehensive health services in terms of physical changes and emotional changes including symptom education, management strategies, and treatment accessibility. Celebrating a woman's health is a beautiful way of making her feel empowered enough so that she can make educated health decisions in her life," she added.&nbsp;

<h2>Issues faced by women after menopause&nbsp;</h2>

Dr Padmapriya, HOD- Department of Obstetrics, gynaecology and fertility medicine, Gleneagles Health City, Chennai, told WION about the various issues faced by women after menopause.&nbsp;

She said, "The major health problems faced by women after menopause is non-cancerous conditions such as endometriosis, fibroids in the uterus and cancerous conditions such as endometrial, cervical, ovarian and breast cancers."&nbsp;

"The main factor linked with increased cancer risk after menopause is the increased exposure to hormones, such as estrogen. Early menarche and late menopause increase the exposure to endogenous estrogen, and thereby increase&nbsp;the risk of above-mentioned conditions," Dr Padmapriya added.&nbsp;

However, with the advancement in surgical technologies, there are better treatment options available for women's health issues after menopause.&nbsp;

Dr Padmapriya said, "Robotic-assisted surgery by using advanced technologies like the da Vinci is one such way."&nbsp;

She added that with its precision and ability to access deeper pelvic areas, robotic surgery ensures maximal removal of abnormal tissues, potentially improving patient outcomes and quality of life.&nbsp;

The enhanced adoption of such technologies in India gives new hope to women to tackle their health problems more effectively after menopause, she said.&nbsp;

Among other deterrents, the biological clock is one of the factors that pose a roadblock in women's career progression. Women face sexism, unequal pay, gender stereotypes, fewer promotions, and other inequalities in workplaces; and learn to fight them all.

Among other deterrents, the biological clock is one of the factors that pose a roadblock in women's career progression. Women face sexism, unequal pay, gender stereotypes, fewer promotions, and other inequalities in workplaces; and learn to fight them all. But in order to maintain respectable career growth, women often sideline their health which keeps deteriorating with time. One such health-related concern is the stage of menopause, which is a natural decline in reproductive hormones when a woman reaches her 40s or 50s. Menopause means that your menstrual cycles are ending. This natural biological process is diagnosed after you've gone 12 months without a menstrual period. Also read: Rising cases of silent heart attacks linked to long Covid? WION decodes Despite being a natural process, the physical and mental symptoms of menopause, such as hot flashes, can disrupt your sleep, diminish your energy, and have an impact on your emotional health. WION got in touch with experts to know how women can embrace this crucial phase along with focusing on their career and personal life. Dr Rituparna Ghosh, Consultant Senior Clinical Psychologist, Apollo Hospitals, Navi Mumbai told WION, "Embracing menopause with confidence means acknowledging its challenges while harnessing the resilience and wisdom gained from navigating life's transitions." "Let us foster environments where women feel empowered to seek support, openly discuss their experiences, and embrace self-care practices that nurture their mind, body, and spirit. Together, let's dismantle stigmas surrounding menopause and empower women to embrace this chapter of life with confidence, resilience, and a renewed sense of purpose," she added. Dr VK Shantha, MD, DGO, DNB, Senior Consultant Obstetrician & Gynecologist, BirthRight by Rainbow Hospitals, Anna Nagar, Chennai told WION, "The menopausal transition is a crucial phase in a woman's life, with various changes such as caring for ageing parents, supporting children, and accepting new obligations." The World Health Organization (WHO) states that most women go through menopause between the ages of 45 and 55 as a natural component of biological ageing. Some women are luckier than the rest and face fewer issues with menstrual symptoms, while others go through hot flashes, difficulty in sleeping, sexual dysfunction, mood swings, anger, sadness, or a combination of these symptoms, encouraging them to seek treatment. Also read: Research outlines significant changes that happen to body during pregnancy A decades-old study had accurately projected the future as it noted that using age 50 as a proxy for menopause, about 25 million women pass through menopause each year. The study estimated that in 1990 there were 467 million post-menopausal women in the world, with an average age of about 60 years. It mentioned that by 2030, the world population of menopausal and postmenopausal women is projected to increase to 1.2 billion, with 47 million new entrants each year. Dr Shantha added, "As medical professionals, we must acknowledge this natural shift and provide women with the knowledge, support, and confidence they require to manage it with grace and resilience." "Women need comprehensive health services in terms of physical changes and emotional changes including symptom education, management strategies, and treatment accessibility. Celebrating a woman's health is a beautiful way of making her feel empowered enough so that she can make educated health decisions in her life," she added. Issues faced by women after menopause Dr Padmapriya, HOD- Department of Obstetrics, gynaecology and fertility medicine, Gleneagles Health City, Chennai, told WION about the various issues faced by women after menopause. She said, "The major health problems faced by women after menopause is non-cancerous conditions such as endometriosis, fibroids in the uterus and cancerous conditions such as endometrial, cervical, ovarian and breast cancers." "The main factor linked with increased cancer risk after menopause is the increased exposure to hormones, such as estrogen. Early menarche and late menopause increase the exposure to endogenous estrogen, and thereby increase the risk of above-mentioned conditions," Dr Padmapriya added. However, with the advancement in surgical technologies, there are better treatment options available for women's health issues after menopause. Dr Padmapriya said, "Robotic-assisted surgery by using advanced technologies like the da Vinci is one such way." She added that with its precision and ability to access deeper pelvic areas, robotic surgery ensures maximal removal of abnormal tissues, potentially improving patient outcomes and quality of life. The enhanced adoption of such technologies in India gives new hope to women to tackle their health problems more effectively after menopause, she said.

Don't let menopause pause you, embrace it with confidence and dismantle stigmas

A drug that can potentially offer relief to hundreds of thousands of women battling hot flushes during menopause has been approved in the UK.

The drug named Veoza or&nbsp;fezolinetant has been approved by UK's Medicines and Healthcare Products Regulatory Agency (MHRA). Previously, it was cleared for use in the United States by the US Foods and Drug Administration.&nbsp;

<h2>Hot flushes: A common problem</h2>

Hot flushes, as per The Guardian, effect, around 70 per cent of menopausal women around the world, negatively impacting their&nbsp;daily lives, disrupting activities like exercise, sleep, etc.

Also read |&nbsp;<a href="https://www.wionews.com/science/african-scientist-develops-gene-drive-tech-that-could-wipe-out-malaria-from-continent-670570">African scientist develops ‘gene drive tech’ that could wipe out malaria from continent</a>

Currently, hormone replacement therapy (HRT) is the most effective treatment available for hot flushes. However, a number of&nbsp;factors, such as side effects, a history of breast or ovarian cancer, blood clots, or untreated high blood pressure, make it unsuitable for everyone. Furthermore, some women simply prefer non-hormonal options.&nbsp;

<h2>How Veoza works</h2>

Veoza, which is a non-hormonal menopause drug, directly targets the brain to prevent hot flushes by blocking a protein called neurokinin-3.&nbsp;Although it is not recommended for women over 65, the drug has the potential to provide relief for women for whom HRT is not suitable.

The cost of the treatment for the UK is yet to be decided. However,&nbsp;in the US, it costs&nbsp;$550 (£430) for a 30-day supply.&nbsp;

Veoza acts directly on the brain's temperature control pathway without replacing estrogen, offering a novel mechanism of action for treating moderate to severe vasomotor symptoms associated with menopause.

Also read |&nbsp;<a href="https://www.wionews.com/technology/australian-researchers-building-worlds-first-human-brain-scale-computer-it-will-go-online-next-year-670693">Australian researchers building world's first human brain-scale computer. It will go online next year</a>

A large clinical trial of the medicine showed a 60 per cent reduction in the frequency of hot flushes after 12 weeks of use in women with moderate or severe symptoms. Experts have hailed Veoza as a "completely blockbuster drug".

Talking to The Guardian, Julian Beach, the interim executive director of healthcare quality and access at MHRA, said: "Hot flushes and night sweats caused by menopause are common, and can have a significant impact on a woman’s daily life. We are therefore pleased to have authorised Veoza (fezolinetant) for hot flushes and night sweats caused by menopause via our reliance procedure."

"No medicine would be approved unless it met our expected standards of safety, quality and effectiveness, and we continue to keep the safety of all medicines under close review," emphasised Beach.

The drug, which is prescription only, will be available privately from January 5, said the company&nbsp;Astellas., the company that made the drug. Astellas said that it is applying for access through the National Institute for Health and Care Excellence to make it available on the NHS.

(With inputs from agencies)

A drug that can potentially offer relief to hundreds of thousands of women battling hot flushes during menopause has been approved in the UK. The drug named Veoza or fezolinetant has been approved by UK's Medicines and Healthcare Products Regulatory Agency (MHRA).

A drug that can potentially offer relief to hundreds of thousands of women battling hot flushes during menopause has been approved in the UK. The drug named Veoza or fezolinetant has been approved by UK's Medicines and Healthcare Products Regulatory Agency (MHRA). Previously, it was cleared for use in the United States by the US Foods and Drug Administration. Hot flushes: A common problem Hot flushes, as per The Guardian, effect, around 70 per cent of menopausal women around the world, negatively impacting their daily lives, disrupting activities like exercise, sleep, etc. Also read | African scientist develops ‘gene drive tech’ that could wipe out malaria from continent Currently, hormone replacement therapy (HRT) is the most effective treatment available for hot flushes. However, a number of factors, such as side effects, a history of breast or ovarian cancer, blood clots, or untreated high blood pressure, make it unsuitable for everyone. Furthermore, some women simply prefer non-hormonal options. How Veoza works Veoza, which is a non-hormonal menopause drug, directly targets the brain to prevent hot flushes by blocking a protein called neurokinin-3. Although it is not recommended for women over 65, the drug has the potential to provide relief for women for whom HRT is not suitable. The cost of the treatment for the UK is yet to be decided. However, in the US, it costs $550 (£430) for a 30-day supply. Veoza acts directly on the brain's temperature control pathway without replacing estrogen, offering a novel mechanism of action for treating moderate to severe vasomotor symptoms associated with menopause. Also read | Australian researchers building world's first human brain-scale computer. It will go online next year A large clinical trial of the medicine showed a 60 per cent reduction in the frequency of hot flushes after 12 weeks of use in women with moderate or severe symptoms. Experts have hailed Veoza as a "completely blockbuster drug". Talking to The Guardian, Julian Beach, the interim executive director of healthcare quality and access at MHRA, said: "Hot flushes and night sweats caused by menopause are common, and can have a significant impact on a woman’s daily life. We are therefore pleased to have authorised Veoza (fezolinetant) for hot flushes and night sweats caused by menopause via our reliance procedure." "No medicine would be approved unless it met our expected standards of safety, quality and effectiveness, and we continue to keep the safety of all medicines under close review," emphasised Beach. The drug, which is prescription only, will be available privately from January 5, said the company Astellas., the company that made the drug. Astellas said that it is applying for access through the National Institute for Health and Care Excellence to make it available on the NHS. (With inputs from agencies)

'Completely blockbuster drug': UK clears the way for drug that treats hot flushes in menopausal women

Researchers in Britain are developing a testosterone hormone patch aimed at helping women combat menopause-related symptoms. If successful, this would be a world first breakthrough that could help women have access to a hormone which is widely available to men.

The patch is being developed to help boost the libido of women with symptoms of menopause, according to news reports.

The testosterone production in women drops drastically post-menopause. This causes issues such as loss of libido, impaired focus, tiredness and headaches.

There are a number of testosterone replacement therapies available to men around the world. But a few that are available to women are in the form of creams and gels, which are tough to dose properly and can rub off on clothing, surfaces and materials.

<h2>Testosterone patches for women: Who is making it?</h2>

The testosterone patches for women are being developed by British company Medherant, founded by David Haddleton, a chemist at England’s University of Warwick.

The company reportedly plans to start clinical trials after testing the patch’s effect on libido in the coming months.

ALSO READ |&nbsp;<a href="https://www.wionews.com/health-and-wellness/data-lab-a-wake-up-call-one-woman-dies-every-2-minutes-in-pregnancy-childbirth-un-566606">Data Lab | A wake-up call: One woman dies every 2 minutes in pregnancy, childbirth: UN</a>

If the trials are successful and the patch is approved by regulators, it could be the first and only testosterone replacement patch available to women worldwide.

ALSO WATCH |&nbsp;'Women of childbearing age shouldn't drink': WHO

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/women-of-childbearing-age-shouldnt-drink-who-392304/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

Haddleton said the impact of the patch on women’s wellbeing could be "huge,"&nbsp;adding that they could potentially "remove needless misery from women’s daily lives."

The company has raised $3.7 million (£3 million) to fund its trials testing the patch.

<h2>Testosterone patches for women: Why is it important?</h2>

Women around the world are often prescribed the products approved for men "off-label". The lack of a product with specific formulation for women has often been felt. The product-under-testing reportedly aims to fill this exact gap.

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1  width=&quot;100%&quot;"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Researchers in Britain are developing a testosterone hormone patch aimed at helping women combat menopause-related symptoms. If successful, this would be a world first breakthrough that could help women have access to a hormone which is widely available to men.

Researchers in Britain are developing a testosterone hormone patch aimed at helping women combat menopause-related symptoms. If successful, this would be a world first breakthrough that could help women have access to a hormone which is widely available to men. The patch is being developed to help boost the libido of women with symptoms of menopause, according to news reports. The testosterone production in women drops drastically post-menopause. This causes issues such as loss of libido, impaired focus, tiredness and headaches. There are a number of testosterone replacement therapies available to men around the world. But a few that are available to women are in the form of creams and gels, which are tough to dose properly and can rub off on clothing, surfaces and materials. Testosterone patches for women: Who is making it? The testosterone patches for women are being developed by British company Medherant, founded by David Haddleton, a chemist at England’s University of Warwick. The company reportedly plans to start clinical trials after testing the patch’s effect on libido in the coming months. ALSO READ | Data Lab | A wake-up call: One woman dies every 2 minutes in pregnancy, childbirth: UN If the trials are successful and the patch is approved by regulators, it could be the first and only testosterone replacement patch available to women worldwide. ALSO WATCH | 'Women of childbearing age shouldn't drink': WHO × Haddleton said the impact of the patch on women’s wellbeing could be "huge," adding that they could potentially "remove needless misery from women’s daily lives." The company has raised $3.7 million (£3 million) to fund its trials testing the patch. Testosterone patches for women: Why is it important? Women around the world are often prescribed the products approved for men "off-label". The lack of a product with specific formulation for women has often been felt. The product-under-testing reportedly aims to fill this exact gap. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Scientists close to developing testosterone patches to help women combat menopause-related issues